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        Rheumatoid arthritis (RA) is a chronic systemic 
infl  ammatory disease that primarily aff  ects mul-
tiple joints. Autoimmune CD4  +   T cells are re-
quired for the progression of RA, especially in 
an initial phase of the disease (  1  ). It is obscure, 
however, how such arthritogenic CD4  +   T cells 
are produced in the immune system, become 
activated, and mediate RA. Recent studies with 
animal models have suggested that CD4  +   T 
cells secreting IL-17 (IL-17A), called Th17 
cells, may play a key role in the progression of 
RA as well as multiple sclerosis (  2  –  6  ). Hindering 
the development of Th17 cells or blocking IL-17 
activity indeed inhibits autoimmune pathology 
in these models (  2  –  6  ). A particular cytokine 
milieu contributes to this preferential diff  er-
entiation of naive self-reactive T cells to Th17 
eff  ector cells (  2  –  6  ). In addition, the transcrip-
tion factor ROR    t specifi  cally controls Th17 
cell diff  erentiation, indicating that Th17 cells 
form a T cell lineage distinct from Th1 or Th2 
cells (  7  ). To further analyze the roles of Th17 
cells in autoimmune disease, we have searched 
for cell-surface molecules that are specifi  cally 
expressed in Th17 cells and are crucial for their 
functions, such as their migration to infl  amed 
joints in RA. 
  The SKG strain of mice, a mutant on the 
BALB/c background, spontaneously develops 
T cell  –  mediated autoimmune arthritis, which 
clinically and immunologically resembles hu-
man RA (  8  –  10  ). The strain harbors a recessive 
mutation of the gene encoding an Src homol-
ogy 2 domain of     -associated protein 70, a key 
signaling molecule in T cells. Impaired signal 
transduction through SKG     -associated protein 
70 results in thymic positive selection and failure 
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  This report shows that interleukin (IL) 17  –  producing T helper type 17 (Th17) cells predomi-
nantly express CC chemokine receptor (CCR) 6 in an animal model of rheumatoid arthritis 
(RA). Th17 cells induced in vivo in normal mice via homeostatic proliferation similarly 
express CCR6, whereas those inducible in vitro by transforming growth factor      and IL-6 
additionally need IL-1 and neutralization of interferon (IFN)      and IL-4 for CCR6 ex-
pression. Forced expression of ROR    t, a key transcription factor for Th17 cell differentia-
tion, induces not only IL-17 but also CCR6 in naive T cells. Furthermore, Th17 cells produce 
CCL20, the known ligand for CCR6. Synoviocytes from arthritic joints of mice and humans 
also produce a large amount of CCL20, with a signifi  cant correlation (P = 0.014) between 
the amounts of IL-17 and CCL20 in RA joints. The CCL20 production by synoviocytes is 
augmented in vitro by IL-1    , IL-17, or tumor necrosis factor     , and is suppressed by IFN-     
or IL-4. Administration of blocking anti-CCR6 monoclonal antibody substantially inhibits 
mouse arthritis. Thus, the joint cytokine milieu formed by T cells and synovial cells controls 
the production of CCL20 and, consequently, the recruitment of CCR6  +   arthritogenic Th17 
cells to the infl  amed joints. These results indicate that CCR6 expression contributes to 
Th17 cell function in autoimmune disease, especially in autoimmune arthritis such as RA. 2804 CCR6- AND CCL20-DEPENDENT MIGRATION OF ARTHRITOGENIC TH17 CELLS | Hirota et al.
  Figure 1.     Gene microarray analysis of Th17 cells and their predominant expression of CCR6. (A) LN CD4  +   T cells from 10-mo-old BALB/c or SKG 
mice were stained for intracellular IL-17 and IFN-    , or these cytokines and cell-surface FR4. (B) CD4  +   T cells from IFN-     − / −    or  IL-6  − / −    mice were transferred 
to RAG2   − / −    mice or IL-6   − / −  RAG2  − / −    mice, respectively. Intracellular IL-17 and IFN-     in recipient splenic CD4  +   T cells were stained on day 7. (C) Purifi  ed 
FR4   −  CD4 +   T cells from BALB/c or SKG mice or CD4  +   T cells after homeostatic proliferation, as shown in A and B, were stimulated with PMA/ionomycin for 3 h, JEM VOL. 204, November 26, 2007  2805
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BALB/c FR4    −   CD4  +   cells, and between IFN-        −  /  −   CD4  +   cells 
and IL-6    −  /  −   CD4  +   T cells transferred to RAG2    −  /  −    mice, as de-
scribed in the previous paragraph. The analysis revealed that 
1,556 and 115 genes were up-regulated in 10-mo-old SKG 
FR4    −   CD4  +   and IFN-        −  /  −   CD4  +   T cells after homeostatic pro-
liferation, respectively, with 29 genes shared by the two 
groups of genes (  Fig. 1 D  ). The 29 genes included those encod-
ing cytokines, chemokines, and their receptors, such as IL-1R1, 
IL-17, IL-22, IL-21, CCR6, and CCL20 (  Fig. 1 E  ; the rest 
of the genes are shown in Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20071397). 
  Expression of CCR6 by Th17 cells 
  With our interest in Th17 cell  –  specifi  c cell-surface mole-
cules, we analyzed CCR6 expressed by Th17 cells in young 
(2-mo-old) or aged (10-mo-old) SKG mice, or BALB/c 
Th17 cells induced via homeostatic proliferation (  Fig. 1 B  ). 
The majority of Th17 cells in SKG mice expressed CCR6 
whether the mice were young or aged, whereas SKG Th1 
cells did not (  Fig. 1 F  ). After cell transfer to RAG2    −  /  −    mice, 
the majority of IL-17  +  CD4  +   T cells that had diff  erentiated 
from IFN-        −  /  −    or WT T cells were CCR6  +  , whereas IFN-      +   
CD4  +   T cells derived from WT CD4  +   T cells were CCR6    −    
(  Fig. 1 G  ). Furthermore, IL-6    −  /  −   CD4  +   T cells not only failed 
to give rise to IL-17  +  CCR6  +   cells but also preferentially dif-
ferentiated to IFN-      +  CCR6    −    cells (  Fig. 1 G  ). 
  It was also noted that CCR6  +   cells, either IL-17  +   or IL-17    −   , 
increased in number among CD4  +   T cells in aged SKG mice 
compared with aged BALB/c or young SKG mice (  Fig. 1 F   
and Fig. S2 A, available at http://www.jem.org/cgi/content/
full/jem.20071397). Both IL-17  +  CCR6  +   and IL-17    −   CCR6  +   
populations similarly increased in RAG2    −  /  −    mice transferred 
with IFN-        −  /  −    cells and, to a lesser extent, in those   transferred 
with WT T cells, but not in IL-6    −  /  −    cell –  transferred RAG2    −  /  −    
mice (  Fig. 1 G   and Fig. S2 B). In addition, CCR6    −   CD4  +   T 
cells in BALB/c mice gave rise to IL-17  +  CCR6  +  CD4  +   T cells 
via homeostatic proliferation when transferred to RAG2    −  /  −    
mice (Fig. S2 C). 
  We also examined a possible correlation between CCR6 
expression and transcription of the other genes depicted by 
the microarray analysis in   Fig. 1 E   or those genes reported to 
be functional in Th17 cells (e.g., IL-17, IL-17F, IL-21, IL-22, 
IL-1R1, IL-23R, and ROR    t;   Fig. 1 H  ) (  7, 13, 14  ). When 
CCR6  +   or CCR6    −    CD4  +   T cells purifi  ed from aged SKG mice 
in the negative selection of highly self-reactive T cells that 
include potentially arthritogenic CD4  +   T cells (  8  ). Our previous 
report showed that SKG CD4  +   T cells spontaneously diff  er-
entiated to arthritogenic Th17 cells, which were nonredundant 
in mediating SKG arthritis (  6  ). The study also showed that 
not only self-reactive CD4  +   T cells in SKG mice but also 
  naive T cells in normal mice were able to diff  erentiate to Th17 
cells when they were subjected to homeostatic proliferation 
in a T cell  –  defi  cient environment (  6  ). In both systems, IL-6 
defi  ciency inhibited Th17 cell diff  erentiation, whereas IFN-     
defi  ciency augmented it (  6  ). Use of these two in vivo Th17 
cell induction systems allowed us to determine the genes 
commonly up-regulated in Th17 cells. We show in this re-
port that Th17 cells predominantly express CC chemokine 
receptor (CCR) 6 and produce its ligand, CCL20. Infl  amed 
synovial cells in both SKG arthritis and human RA also pro-
duce CCL20, facilitating the migration of arthritogenic Th17 
cells to infl  amed joints. Thus, CCR6 is an important func-
tional marker for Th17 cells and contributes to their prefer-
ential migration to a particular infl  ammation site. 
    RESULTS AND DISCUSSION   
  Gene microarray analysis of Th17 cells 
  Th17 cells increase with age in SKG mice, constituting 
    3  –  10% of LN CD4  +   T cells at 10 mo of age compared with 
    0.2  –  0.7% in age-matched BALB/c mice (  Fig. 1 A  ).   Nota-
bly, they scarcely express the folate receptor 4 (FR4), which 
is highly expressed by CD25  +  CD4  +   natural regulatory T cells 
and central memory-like CD4  +   T cells but not by eff  ector or 
eff  ector memory-like CD4  +   T cells (  Fig. 1 A  ) (  11  –  12  ). Th17 
cells can therefore be enriched by sorting FR4    −   CD4  +   T cells 
from SKG mice. A large number of Th17 cells also   developed 
spontaneously when CD4  +   T cells from IFN-      –  defi  cient 
(IFN-        −  /  −   ) BALB/c mice were transferred to T cell  –    defi  cient 
RAG2-defi  cient (RAG2    −  /  −   ) mice and subjected to homeo-
static proliferation, whereas they failed to develop in a similar 
transfer of IL-6  –  defi  cient (IL-6    −  /  −   ) CD4  +   T cells to IL-6    −  /  −    
RAG2    −  /  −    mice (  Fig. 1 B  ) (  6  ). The numbers of Th17 cells as-
sessed by cytofl  uorometric analysis were well correlated with 
the amounts of the IL-17 protein secreted after in vitro stim-
ulation with PMA/ionomycin (  Fig. 1 C  ). 
  To explore the functional molecules specifi  cally expressed 
by Th17 cells, we conducted gene microarray analysis be-
tween 10-mo-old SKG FR4    −   CD4  +   cells and age-matched 
and the amounts of IL-17 in culture supernatants were measured by ELISA. (D and E) Total RNA extracted from activated cells, as shown in C, was sub-
jected to gene microarray for SKG versus BALB/c FR4   −  CD4 +   T cells or IFN-     − / −    versus  IL-6  − / −  CD4 +   T cells after homeostatic proliferation. The expression of 
each gene was averaged from three independent experiments and analyzed by GeneSpring software. The Venn diagram shown in D represents a group of 
up-regulated genes in SKG FR4   −  CD4 +   T cells and IFN-     − / −  CD4 +   T cells after homeostatic proliferation. Genes for cytokines, chemokines, or their receptors 
commonly up-regulated in the two groups of genes are shown in E. Graded colors represent relative expression levels. (F) LN CD4  +   T cells from 2- or 
10-mo-old SKG mice were stained for CCR6 and intracellular IL-17 or IFN-    . (G) CD4  +   T cells from IFN-     − / −  ,  IL-6  − / −   , or WT mice were stained for CCR6 
and intracellular IL-17 or IFN-     after homeostatic proliferation, as shown in B. (H) Total RNA extracted from purifi  ed SKG CCR6  +   or  CCR6  −  CD4 +   T  cells 
stimulated with PMA/ionomycin for 3 h was subjected to quantitative RT-PCR for the indicated genes and normalized for hypoxanthine-guanine phos-
phoribosyltransferase (HPRT) messenger RNA expression, as previously described (reference   7  ). Data are shown as the mean   ±   SD of three independent 
experiments. Results in A  –  C, F, and G represent three to fi  ve independent experiments. The percentage of cells in each quadrant is shown in A, B, F, and G.     
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were activated in vitro with PMA/ionomycin and expression 
levels of individual genes were analyzed by quantitative RT-
PCR, CCR6  +  CD4  +   SKG T cells indeed transcribed most of 
the genes much more actively than CCR6    −   CD4  +   T cells, in 
contrast with much less transcription of the IFN-     gene. As 
both aged SKG CD4  +   T cells and BALB/c IFN-        −  /  −   CD4  +   
T cells highly expressed the   Il1r1   gene after homeostatic pro-
liferation (  Fig. 1 E  ), IL-17  +  CD4  +   T cells in aged SKG mice 
expressed the IL-1R1 protein higher than IL-17    −   CD4  +   T cells 
by cytofl  uorometric analysis (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20071397). 
  Previous studies with mice have shown that CCR6 is mainly 
expressed on memory T cells, some natural CD25  +  CD4  +   
regulatory T cells, B cells, some DCs, and Langerhans cells, 
and suggested that CCR6 may be required for the traffi   cking 
of these cells via CCL20 (  15  –  20  ). The present results show 
that, in addition to these cell populations, Th17 cells also 
express CCR6 and that CCR6 expression can distinguish 
Th17 cells from Th1 cells. The condition that facilitates 
in vivo Th17 cell diff  erentiation might also promote diff  eren-
tiation of naive CD4  +   T cell to CCR6  +  IL-17    −   IFN-        −    cells, 
which are FR4 high and, therefore, phenotypically similar to 
natural CD25  +  CD4  +   regulatory T cells and central   memory-
like T cells, as recently shown (  12  ), and in accord with the 
results by others (Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20071397). 
  Induction of CCR6 in Th17 cells in vitro 
  ROR    t crucially controls Th17 cell differentiation from 
naive CD4  +   T cells (  7  ). To test whether forced expression of 
ROR    t directs the diff  erentiation of CD4  +   T cells to CCR6  +   
Th17 cells, ROR    t was transduced in CCR6    −   CD4  +   T cells 
by a bicistronic retroviral vector expressing ROR    t and GFP 
(  7  ). Notably, GFP-high (i.e., ROR    t-high) cells expressed 
CCR6 as well as IL-17, whereas GFP-low cells did not (  Fig. 2, 
A and B  ).   Th17 cells can also be induced in vitro from naive 
CD4  +   T cells by TCR stimulation in the presence of IL-6 
and TGF-    , as reported by others (  21  –  23  ). Interestingly, this 
in vitro induction of a large number of Th17 cells did not ac-
company CCR6 expression (  Fig. 2 C  ). Yet, further addition 
of IL-1, based on the high expression of IL-1R by IL-17  +   
cells (  Fig. 1 E   and Fig. S3), elicited CCR6 expression in a 
  Figure 2.     Induction of CCR6 on Th17 cells in vitro. (A) Retroviral vector, pMxs-ROR   t-IRES-GFP  (ROR   t-IG), or control pMxs-IRES-GFP (Control-IG), was 
transduced into BALB/c CCR6   −  CD4 +   T cells, as previously described (reference   7  ), and the cells expressing GFP were stained for CCR6 on day 4 after transduction. 
(B) The mean percentages   ±   SD of CCR6  +   or  IL-17 +   cells among CD4  + GFP high   cells (as gated in A) in three independent experiments are shown. (C) CD4  + CD25  −  CCR6  −   
T cells were in vitro driven to differentiate to Th17 cells in the indicated conditions, as previously described (reference   21  ). CCR6 and intracellular IL-17 gated on 
CD4  +   T cells were stained on day 5. Results in A and C represent three independent experiments, and the percentage of cells in each quadrant is shown.    JEM VOL. 204, November 26, 2007  2807
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  Figure 3.     Cross-regulation of synoviocyte CCL20 production by cytokines and preferential migration of Th17 cells in response to CCL20. (A) 2.5   ×   
10  4   adherent synoviocytes, prepared as previously described (reference   10  ), were cultured with 10 ng/ml of the indicated cytokine for 24 h. The amounts of 
CCL20 in culture supernatants were measured by ELISA. Data are shown as the mean   ±   SD of triplicate wells. (B and C) Purifi  ed CCR6  +   or  CCR6  −  CD4 +   T  cells 
from SKG mice were stimulated with PMA/ionomycin for 3 h; CCL20 messenger RNA was assessed by quantitative RT-PCR (B), and CCL20 protein was mea-
sured by ELISA (C). Data are shown as the mean   ±   SD of three independent experiments. (D) CD4  +   T cells were in vitro driven to differentiate to Th17 cells in 
the presence of IL-6 and TGF-    , as previously described (reference   21  ). Cells were restimulated with PMA/ionomycin for 3 h on day 4, and the amounts of 
CCL20 were measured by ELISA. (E) SKG LN cells were placed with 100     g/ml anti-CCR6 antibody or control IgG on the upper well of a Transwell system. The 
migration assay was performed in the presence of designated concentrations of CCL20 added to the bottom well. See Materials and methods for details of 
the experiments. Data are shown as the mean   ±   SD of triplicate wells. (F) The migration assay was performed in the absence or the presence of 50 ng/ml 
CCL20, as in E. CD4  +   cells before being added to the upper well and CD4  +   T cells that had migrated to the lower well were stained for intracellular IL-17 and 
IFN-     (top). Percentages of IL-17  +   or  IFN-   +   cells among CD4  +   cells in the lower wells in three independent migration assays with (+) or without (  −  ) CCL20 
are shown (bottom). Vertical bars represent the means   ±   SD. Results in A, D, and E represent three independent experiments.    2808 CCR6- AND CCL20-DEPENDENT MIGRATION OF ARTHRITOGENIC TH17 CELLS | Hirota et al.
doses used for in vitro Th17 cell induction (  21  ) augmented 
CCL20 production by the adherent synoviocytes, whereas 
the addition of recombinant IFN-     or IL-4 inhibited pro-
duction (  Fig. 3 A  ). Other Th17 cell  –  associated cytokines, 
such as IL-6, IL-22, and IL-23, had no signifi  cant eff  ect on 
the production at the doses used for controlling Th17 cell 
diff  erentiation (  Fig. 3 A  ) (  21  –  23  ). 
  In addition to synoviocytes, purifi  ed CCR6  +  CD4  +   SKG 
T cells actively transcribed CCL20 messenger RNA and se-
creted a large amount of the CCL20 protein compared with 
very low transcription or secretion by CCR6    −   CD4  +   SKG T 
cells (  Fig. 3, B and C  ). This concurred with the result of the 
microarray analysis, which showed a high expression of CCL20 
by SKG FR4    −   CD4  +   T cells and BALB/c IFN-        −  /  −   CD4  +   T 
cells after homeostatic proliferation (  Fig. 1 E  ). In addition, 
Th17 cells that were induced in vitro from normal BALB/c 
CD4  +   T cells by TCR stimulation in the presence of IL-6 and 
TGF-     produced a large amount of CCL20 (  Fig. 3 D  ). 
  Functionally, in vitro migration assays showed that 
CCR6  +  CD4  +   SKG T cells migrated in response to CCL20 
in a dose-dependent manner and that the addition of an anti-
CCR6 mAb, which blocks the binding of CCL20 to CCR6, 
eff  ectively inhibited the migration at such low doses of 
CCL20 as those secreted by cultured synoviocytes in   Fig. 3 A   
(  Fig. 3 E  ). Furthermore, CD4  +   SKG T cells that had mi-
grated in the presence of CCL20 were signifi  cantly enriched 
for IL-17  +   CD4  +   T cells, but not for IFN-      +   CD4  +   T cells, 
small (    15%) fraction of IL-17  +   cells, whereas addition of 
IL-23, TNF-    , or IL-21 did not; the percentage further in-
creased to     30% by neutralization of both IFN-     and IL-4 
(  Fig. 2 C  ). 
  Collectively, these results indicate that, although IL-6 and 
TGF-     together can induce ROR    t at an amount suffi   cient 
for directing IL-17 production in vitro (  7  ), a higher amount 
of ROR    t or additional cytokines including IL-1 may be 
  required for CCR6 expression. Our results also suggest that 
IFN-     and IL-4, both of which inhibit the diff  erentiation of 
naive T cells to Th17 cells (  3  ), may also suppress CCR6 ex-
pression in Th17 cells. 
  CCL20 production by infl  amed synoviocytes and Th17 cells 
  CCL20 is so far known to be the sole ligand for CCR6 and 
able to direct the migration of CCR6  +   cells (  15  –  19  ). To assess 
the possible production of CCL20 in infl  amed synovial tissue 
to attract arthritogenic Th17 cells, collagenase-digested synovial 
tissues from swollen ankle or wrist joints of SKG mice were 
in vitro cultured, as previously described ( 10  ), and the amounts 
of CCL20 in culture supernatants were   measured by ELISA. 
The dispersed granulocytes and monocytes from the infl  amed 
synovial tissue, or the splenocytes of arthritic mice, did not 
produce CCL20 without stimulation ( Fig. 3 A  and not depicted).  
Notably, adherent synovial cells, mainly fi  broblast-like syn-
oviocytes, spontaneously produced CCL20 (  Fig. 3 A  ). Adding 
recombinant IL-1    , IL-17, or TNF-     to the culture at the 
  Figure 4.     Contribution of CCR6/CCL20 to traffi  cking of Th17 cells in SKG arthritis. (A) CD4  +   T cells infi  ltrating arthritic joints were prepared 
from collagenase-digested ankle joints of SKG mice, and stained for CCR6 and intracellular IL-17 or IFN-    . (B) SKG mice received an i.v. injection of 100 
    g anti-CCR6 antibody or control IgG; LN cells were stained by anti  –  rat IgG and CD4 48 h after injection. The percentage of cells in each quadrant is 
shown in A and B. (C) SCID mice received an i.v. injection of 10  6   SKG  CD4 +   T cells, and then injections of 100     g anti-CCR6 mAb or control IgG once a 
week for 5 wk. The arrows indicate i.v. injections of anti-CCR6 mAb. The incidence and severity of arthritis was scored every week, as previously described 
(reference   8  ). Vertical bars represent the means   ±   SEM. The disease curves of arthritis scores are signifi  cantly different between the two groups (P   <   0.005 
according to the analysis of covariance test). The differences in scores are statistically signifi  cant (according to the Mann-Whitney U test) in the 8th 
(*, P = 0.04), 9th (*, P = 0.02), and 10th (*, P = 0.04) wk. Results in A and B represent three independent experiments.     JEM VOL. 204, November 26, 2007  2809
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indicating that Th17 cells preferentially migrated in response 
to CCL20, whereas Th1 cells did not (  Fig. 3 F  ). 
  Collectively, these results indicate that both activated syn-
oviocytes and CCR6  +  Th17 cells themselves secrete CCL20 
and further recruit other CCR6-expressing Th17 cells to the 
site of Th17 cell  –  mediated joint infl  ammation. 
  The effect of CCR6 blockade on the initial phase of Th17 
cell  –  mediated arthritis 
  We previously reported that Th17 cells predominantly infi  l-
trated into the arthritic joints of SKG mice (  6  ). These infi  ltrating 
Th17 cells indeed expressed CCR6, in contrast with infi  ltrat-
ing Th1 cells, which were CCR6    −    (  Fig. 4 A  ).   To investigate 
the role of CCR6 on SKG autoimmune arthritis, we initially 
examined the eff  ect of in vivo anti-CCR6 mAb treatment on 
lymphocytes. The anti-CCR6 mAb, which was used for 
in vitro CCR6 blockade (  Fig. 3 E  ), was not cell depleting 
in vivo: after one injection into SKG mice, it bound to 
CCR6 on the cell surface of B cells and a population of CD4  +   
T cells, and the binding persisted for at least 8 d (  Fig. 4 B   and 
Fig. S5, available at http://www.jem.org/cgi/content/full/
jem.20071397). To assess the eff  ect of this CCR6 blockade 
  Figure 5.     Production of IL-17 and CCL20 in RA joints. (A and B) The concentrations of IL-17 and CCL20 in synovial fl  uid from RA or OA patients 
were measured by ELISA. Vertical bars represent the means   ±   SD. (C  –  E) Scatter plots show the correlation between IL-17 and IFN-     (C), CCL20 and IFN-    
(D), or CCL20 and IL-17 (E) in the synovial fl  uid of RA patients. RA and OA patients are 66.6   ±   11.6 and 74   ±   7.4 yr old, respectively. r  2   values of Pearson  ’  s 
product-moment correlation and p-values of their null hypothesis are shown. Similar analyses performed only on the samples with the amounts of IL-17, 
IFN-    , or CCL20 detectable by ELISA yielded the following statistics: IL-17 versus CCL20, r  2   = 0.147 and P = 0.177 (  n   = 14); IFN-     versus  CCL20, 
r  2   = 0.0034 and P = 0.481 (  n   = 17); IL-17 versus IFN-   ,  r 2   = 0.359 and P = 0.003 (  n   =  13).   2810 CCR6- AND CCL20-DEPENDENT MIGRATION OF ARTHRITOGENIC TH17 CELLS | Hirota et al.
on the development of arthritis, we transferred SKG CD4  +   
T cells to syngeneic SCID mice and i.v. injected mAb once 
a week for 5 wk after cell transfer (  Fig. 4 C  ). The treatment 
signifi  cantly suppressed the onset and severity of arthritis 
in an early phase: 3 wk after cell transfer, when control anti-
body  –  treated mice started to show joint swelling, much 
smaller number of T cells infi  ltrated into the joints of anti-
CCR6  –  treated mice than control antibody  –  treated mice 
(Fig. S6). Thus, the blockade of CCL20 binding to CCR6 
could suppress the development of Th17 cell  –  mediated auto-
immune arthritis, at least in the initial phase of disease pro-
gression, presumably by interfering with the traffi   cking of 
Th17 cells (  6  ). 
  Production of IL-17 and CCL20 in arthritic joints of 
human RA 
  We extended our analysis of IL-17 and CCR6/CCL20 in 
SKG arthritis to human RA. Synovial fl  uid of RA patients 
contained signifi  cantly higher amounts of IL-17 and CCL20 
compared with osteoarthritis (OA) patients, in accord with 
other reports (  Fig. 5, A and B  ) (  24  –  26  ).   A signifi  cant correla-
tion was observed between the amounts of IL-17 and IFN-     
(  Fig. 5 C  ). Notably, however, the level of CCL20 in RA 
joints was well correlated with that of IL-17 but not of IFN-     
(  Fig. 5, D and E  ). As in mice, intracellular staining of IL-17 
and IFN-     or IL-4 of peripheral CD4  +   T cells in normal 
healthy individuals showed that human Th17 cells were distinct 
from Th1 or Th2 cells and expressed CCR6, whereas CD4  +   
T cells producing IFN-     or IL-4 were CCR6    −    (Fig. S7, avail-
able at http://www.jem.org/cgi/content/full/jem.20071397), 
similar to the result recently reported on human Th17 cells in 
individuals with infectious diseases (  27  ). Collectively, these 
fi  ndings suggest that Th17 cell traffi   cking via CCR6/CCL20 
may contribute to RA pathology. 
  We have thus shown that CCR6 and CCL20 are ex-
pressed by Th17 cells and are required for the migration of 
Th17 cells to initiate self-destructive immune reactions in the 
joints, leading to the development of autoimmune arthritis 
such as RA. Once synovial infl  ammation occurs, synovio-
cytes may further recruit Th17 cells through CCL20 pro-
duction, which is enhanced by proinfl  ammatory cytokines 
produced by activated synoviocytes, such as IL-17, IL-1    , 
and TNF-     (  9  ), and dampened by IFN-     or IL-4. Thus, 
Th1, Th2, and Th17 cell  –  produced cytokines, collectively 
with those produced by synoviocytes, form a cytokine milieu 
to cross-regulate not only the development of Th17 cells but 
also the traffi   cking of CCR6  +   Th17 cells via controlling the 
production of CCL20. It has been shown that joint infi  ltra-
tion of CCR6  +   T cells is associated with human RA, and high 
expression of CCL20 in the central nervous system is observed 
in an animal model of multiple sclerosis (  25, 26, 28  –  30  ). 
It remains to be determined whether intervention in Th17 cell 
traffi   cking via CCR6/CCL20 is useful to treat and prevent 
Th17 cell  –  mediated autoimmune diseases, including RA and 
multiple sclerosis. Such treatments include blocking CCR6 
on Th17 cells at both the initial and chronic phases of disease 
progression and reducing the production of CCL20 by chang-
ing the cytokine milieu at infl  ammation sites. 
  MATERIALS AND METHODS 
  Mice.     BALB/c and SCID mice were purchased from Japan Clea. BALB/c 
IFN-         −  /  −    mice were purchased from the Jackson Laboratory. IL-6    −  /  −    mice 
were backcrossed to BALB/c mice more than eight times. RAG2    −  /  −    BALB/c 
mice were a gift from Y. Shinkai (Kyoto University, Kyoto, Japan) and were 
crossed to IL-6    −  /  −    mice to generate IL-6    −  /  −    RAG2    −  /  −    BALB/c mice. These 
mice were maintained in our animal facility under specifi  c pathogen-free 
conditions and treated in accordance with the institutional guidelines for 
animal care at the Institute for Frontier Medical Sciences of Kyoto University. 
The animal experiments were approved by the animal ethics committee of 
the Institute for Frontier Medical Sciences. 
  Antibodies.     The following reagents were purchased from BD Biosciences: 
anti-CD3 (145-2C11), anti-CD4 (RM4-5), anti-CD16/CD32 (2.4G2), 
anti-TCR         (H57-597), anti-CCR6 (140706), anti  –  IL-4 (11B11), anti  –
  IFN-     (XMG1.2), anti  –  IL-17 (TC11-18H10.1), PE-labeled goat anti  –  rat 
Ig, and isotype control IgG. Purifi  ed anti  –  IL-6R (MR16-1) was a gift from 
N. Nishimoto (Osaka University, Osaka, Japan). Purifi  ed anti-CCR6 (140706) 
was a gift from BD Biosciences. Anti-FR4 (Th6), which is of the rat IgG2a 
isotype, were purifi  ed from the culture supernatant of the hybridoma and 
labeled in our laboratory, as previously described (  12  ). 
  Intracellular cytokine staining.     LN or spleen cells were stimulated with 
20 ng/ml PMA and 1     M ionomycin in the presence of GolgiStop (BD 
Biosciences) for 5 h, stained for surface antigens, fi  xed, and permeabilized 
using Cytofi   x/Cytoperm (BD Biosciences), followed by anti  –  IL-17 and 
anti  –  IFN-     or IL-4 staining. 
  Measurement of cytokines and chemokines.     Mouse IL-17 and CCL20 
were measured by ELISA using Quantikine M (R  &  D Systems), with a detec-
tion limit of 11 pg/ml and 3.9 pg/ml, respectively. Human IL-17, IFN-     
(both from eBioscience), and CCL20 (R  &  D Systems) in synovial fl  uid were 
measured by ELISA, with a detection limit of 4, 8, and 8 pg/ml, respectively. 
  Gene microarray analysis.     Total RNA was extracted using the RNeasy 
Micro Kit (QIAGEN) and was subjected to gene microarray (GeneChip 
Mouse Genome 430 2.0 Array; Aff  ymetrix). Analysis of gene expression was 
performed by GeneSpring software (Agilent Technologies). Microarray data 
are available from the National Center for Biotechnology Information Gene 
Expression Omnibus under accession no.   GSE9316  . 
  Retroviral constructs and transduction.     Complementary DNA (cDNA) 
encoding full-length mouse   Rorgt   was amplifi  ed by RT-PCR from the 
cDNA of SKG CD4  +   T cells and cloned into the pMxs-IRES-GFP vector. 
Retroviral transduction was performed as previously described (  7  ). The 
pMxs-IRES-GFP vector was a gift from T. Kitamura (The University of 
Tokyo, Tokyo, Japan). 
  Preparation of synoviocytes.     Synovial tissues from infl  amed ankle joints 
were digested with 400 Mandl U/ml of Liberase Blendzyme II (Roche) in 
plain RPMI 1640 medium for 1 h at 37  °  C to prepare single-cell suspensions. 
Synovial cells were cultured in RPMI 1640 medium containing 20% FBS, 
and synoviocytes were prepared from the adherent cells. 
  Chemotaxis assay.     Cell migration was evaluated using the 24-well, 5-    m 
pore size Transwell system (Costar). 10  6   LN cells were placed on the top 
of the Transwell in RPMI 1640 containing 10 mM Hepes buff  er. CCL20 
was added to the bottom of the Transwell system in RPMI 1640 contain-
ing 10 mM Hepes buff  er and 1% FBS. After 4 h of incubation at 37  °  C, the 
number of cells that had migrated into the lower well was analyzed by count-
ing CCR6  +   CD4  +   cells for 3 min using a fl  ow cytometer (FACSCalibur; 
BD Biosciences). JEM VOL. 204, November 26, 2007  2811
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  Analysis of synovial fl  uid.     Synovial fl  uid was collected from RA patients, 
fulfilling the revised classification criteria of the American College of 
  Rheumatology for RA, or OA patients during orthopedic operation un-
der written informed consent. The experiments were approved by the 
ethics committee of the Kyoto University Graduate School and Faculty 
of Medicine. 
  Statistical analysis.     The Student  ’  s   t   test was used for statistical analyses, 
unless indicated otherwise. P   ≤   0.05 was considered signifi  cant. 
  Online supplemental material.     Fig. S1 presents the 23 genes, among 
29 genes commonly up-regulated in the two sets of analyses in   Fig. 1 D  , 
that are not encoding cytokines, chemokines, or their receptors. Fig. S2 
shows the expression of CCR6 on BALB/c or SKG CD4  +   T cells and the 
induction of CCR6 after homeostatic proliferation. Fig. S3 exhibits the 
expression of IL-1R1 on Th17 cells. Fig. S4. shows that CCR6  +  CD4  +   T 
cells include not only IL-17  –  producing cells but also TNF-      –  producing 
cells and Foxp3  +   cells. Fig. S5 shows that anti-CCR6 is not a cell-depleting 
  antibody. Fig. S6 shows that the treatment of anti-CCR6 antibody inhibits 
the migration of CCR6  +  CD4  +   cells into the joints of the SCID mice that 
received cell transfer. Fig. S7 demonstrates the expression of CCR6 on 
human Th17 cells. Online supplemental material is available at http://www
.jem.org/cgi/content/full/jem.20071397. 
  The authors thank Dr. Z. Fehervari for critically reading the manuscript and the 
members of our laboratories for valuable comments. 
  This work was supported by Grants-in-Aid from the Ministry of 
Education, Culture, Sports, Science and Technology, and the Japan Science and 
Technology Agency. 
  The authors declare no competing interests. 
Submitted:   9 July 2007 
Accepted:   25 October 2007 
  REFERENCES 
       1  .   Harris  ,   E.D.     1997  . Rheumatoid Arthritis. W.B. Saunders Co., 
Philadelphia. 417 pp.   
       2  .   Langrish  ,   C.L.  ,   Y.     Chen  ,   W.M.     Blumenschein  ,   J.     Mattson  ,   B.     Basham  , 
  J.D.     Sedgwick  ,   T.     McClanahan  ,   R.A.     Kastelein  , and   D.J.     Cua  .   2005  . 
  IL-23 drives a pathogenic T cell population that induces autoimmune 
infl  ammation.       J. Exp. Med.       201  :  233    –    240  .   
       3  .   Harrington  ,  L.E.  ,  R.D.    Hatton  ,  P.R.    Mangan  ,  H.    Turner  ,  T.L.    Murphy  , 
  K.M.     Murphy  , and   C.T.     Weaver  .   2005  .   Interleukin 17-  producing CD4+ 
eff  ector T cells develop via a lineage distinct from the T helper type 1 
and 2 lineages.       Nat. Immunol.       6  :  1123    –    1132  .   
       4  .   Park  ,   H.  ,   Z.     Li  ,   X.O.     Yang  ,   S.H.     Chang  ,   R.     Nurieva  ,   Y.H.     Wang  , 
  Y.     Wang  ,   L.     Hood  ,   Z.     Zhu  ,   Q.     Tian  , and   C.     Dong  .   2005  .   A distinct 
lineage of CD4 T cells regulates tissue infl  ammation by producing inter-
leukin 17.       Nat. Immunol.       6  :  1133    –    1141  .   
       5  .   Nakae  ,   S.  ,   S.     Saijo  ,   R.     Horai  ,   K.     Sudo  ,   S.     Mori  , and   Y.     Iwakura  .   2003  . 
  IL-17 production from activated T cells is required for the spontaneous 
development of destructive arthritis in mice defi  cient in IL-1 receptor 
antagonist.       Proc. Natl. Acad. Sci. USA    .   100  :  5986    –    5990  .   
       6  .   Hirota  ,   K.  ,   M.     Hashimoto  ,   H.     Yoshitomi  ,   S.     Tanaka  ,   T.     Nomura  ,   T.   
  Yamaguchi  ,   Y.     Iwakura  ,   N.     Sakaguchi  , and   S.     Sakaguchi  .   2007  .   T cell 
self-reactivity forms a cytokine milieu for spontaneous development 
of IL-17  +   Th cells that cause autoimmune arthritis.       J. Exp. Med.       204  :
  41    –    47  .   
       7  .   Ivanov  ,   I.I.  ,   B.S.     McKenzie  ,   L.     Zhou  ,   C.E.     Tadokoro  ,   A.     Lepelley  ,   J.J.   
  Lafaille  ,   D.J.     Cua  , and   D.R.     Littman  .   2006  .   The orphan nuclear recep-
tor RORgammat directs the diff  erentiation program of proinfl  amma-
tory IL-17+ T helper cells.       Cell    .   126  :  1121    –    1133  .   
       8  .   Sakaguchi  ,   N.  ,   T.     Takahashi  ,   H.     Hata  ,   T.     Nomura  ,   T.     Tagami  ,   S.   
  Yamazaki  ,   T.     Sakihama  ,   T.     Matsutani  ,   I.     Negishi  ,   S.     Nakatsuru  , and 
  S.     Sakaguchi  .   2003  .   Altered thymic T-cell selection due to a   mutation 
of the ZAP-70 gene causes autoimmune arthritis in mice.       Nature    . 
  426  :  454    –    460  .   
       9  .   Hata  ,   H.  ,   N.     Sakaguchi  ,   H.     Yoshitomi  ,   Y.     Iwakura  ,   K.     Sekikawa  ,   Y.   
  Azuma  ,   C.     Kanai  ,   E.     Moriizumi  ,   T.     Nomura  ,   T.     Nakamura  , and   S.   
  Sakaguchi  .   2004  .   Distinct contribution of IL-6, TNF-alpha, IL-1, and 
IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.   
    J. Clin. Invest.       114  :  582    –    588  .   
        10  .   Yoshitomi  ,   H.  ,   N.     Sakaguchi  ,   K.     Kobayashi  ,   G.D.     Brown  ,   T.     Tagami  , 
  T.     Sakihama  ,   K.     Hirota  ,   S.     Tanaka  ,   T.     Nomura  ,   I.     Miki  ,   et al  .   2005  .   A 
role for fungal     -glucans and their receptor Dectin-1 in the induction 
of autoimmune arthritis in genetically susceptible mice.       J. Exp. Med.     
  201  :  949    –    960  .   
        11  .   Sakaguchi  ,   S.     2005  .   Naturally arising Foxp3-expressing CD25+CD4+ 
regulatory T cells in immunological tolerance to self and non-self.   
    Nat. Immunol.       6  :  345    –    352  .   
        12  .   Yamaguchi  ,   T.  ,   K.     Hirota  ,   K.     Nagahama  ,   K.     Ohkawa  ,   T.     Takahashi  ,   T.   
  Nomura  , and   S.     Sakaguchi  .   2007  .   Control of immune responses by 
antigen-specifi  c regulatory T cells expressing the folate receptor.       Immunity    . 
  27  :  145    –    159  .   
        13  .   Sutton  ,   C.  ,   C.     Brereton  ,   B.     Keogh  ,   K.H.     Mills  , and   E.C.     Lavelle  .   2006  . 
  A crucial role for interleukin (IL) 1 in the induction of IL-17  –  producing 
T cells that mediate autoimmune encephalomyelitis.       J. Exp. Med.       203  :
  1685    –    1691  .   
        14  .   Zheng  ,   Y.  ,   D.M.     Danilenko  ,   P.     Valdez  ,   I.     Kasman  ,   J.     Eastham-
Anderson  ,   J.     Wu  , and   W.     Ouyang  .   2007  .   Interleukin-22, a T(H)17 
cyto  kine, mediates IL-23-induced dermal infl  ammation and acanthosis.   
    Nature    .   445  :  648    –    651  .   
        15  .   Liao  ,   F.  ,   R.L.     Rabin  ,   C.S.     Smith  ,   G.     Sharma  ,   T.B.     Nutman  , and   J.M.   
  Farber  .   1999  .   CC-chemokine receptor 6 is expressed on diverse mem-
ory subsets of T cells and determines responsiveness to macrophage 
infl  ammatory protein 3 alpha.       J. Immunol.       162  :  186    –    194  .   
        16  .   Charbonnier  ,   A.S.  ,   N.     Kohrgruber  ,   E.     Kriehuber  ,   G.     Stingl  ,   A.     Rot  , 
and   D.     Maurer  .   1999  .   Macrophage infl  ammatory protein 3     is involved 
in the constitutive traffi   cking of epidermal Langerhans cells.       J. Exp. Med.     
  190  :  1755    –    1768  .   
        17  .   Dieu-Nosjean  ,   M.C.  ,   C.     Massacrier  ,   B.     Homey  ,   B.     Vanbervliet  ,   J.J.     Pin  , 
  A.     Vicari  ,   S.     Lebecque  ,   C.     Dezutter-Dambuyant  ,   D.     Schmitt  ,   A.     Zlotnik  , 
and   C.     Caux  .   2000  .   Macrophage infl  ammatory protein 3     is expressed at 
infl  amed epithelial surfaces and is the most potent chemokine known in 
attracting Langerhans cell precursors.       J. Exp. Med.       192  :  705    –    718  .   
        18  .   Iwasaki  ,   A.  , and   B.L.     Kelsall  .   2000  .   Localization of distinct Peyer  ’  s patch 
dendritic cell subsets and their recruitment by chemokines macrophage 
infl  ammatory protein (MIP)  –  3    , MIP-3    , and secondary lymphoid 
  organ chemokine.       J. Exp. Med.       191  :  1381    –    1394  .   
        19  .   Le Borgne  ,   M.  ,   N.     Etchart  ,   A.     Goubier  ,   S.A.     Lira  ,   J.C.     Sirard  ,   N.   
  van Rooijen  ,   C.     Caux  ,   S.     Ait-Yahia  ,   A.     Vicari  ,   D.     Kaiserlian  , and   B.   
  Dubois  .   2006  .   Dendritic cells rapidly recruited into epithelial tissues via 
CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.   
    Immunity    .   24  :  191    –    201  .   
        20  .   Kleinewietfeld  ,   M.  ,   F.     Puentes  ,   G.     Borsellino  ,   L.     Battistini  ,   O.   
  Rotzschke  , and   K.     Falk  .   2005  .   CCR6 expression defi  nes regulatory 
eff  ector/memory-like cells within the CD25(+)CD4+ T-cell subset.   
    Blood    .   105  :  2877    –    2886  .   
        21  .   Veldhoen  ,   M.  ,   R.J.     Hocking  ,   C.J.     Atkins  ,   R.M.     Locksley  , and   B.   
  Stockinger  .   2006  .   TGFbeta in the context of an infl  ammatory cyto-
kine milieu supports de novo diff  erentiation of IL-17-producing T cells.   
    Immunity    .   24  :  179    –    189  .   
        22  .   Bettelli  ,   E.  ,   Y.     Carrier  ,   W.     Gao  ,   T.     Korn  ,   T.B.     Strom  ,   M.     Oukka  ,   H.L.   
  Weiner  , and   V.K.     Kuchroo  .   2006  .   Reciprocal developmental pathways 
for the generation of pathogenic eff  ector TH17 and regulatory T cells.   
    Nature    .   441  :  235    –    238  .   
        23  .   Mangan  ,   P.R.  ,   L.E.     Harrington  ,   D.B.     O  ’  Quinn  ,   W.S.     Helms  ,   D.C.   
  Bullard  ,   C.O.     Elson  ,   R.D.     Hatton  ,   S.M.     Wahl  ,   T.R.     Schoeb  , and   C.T.   
  Weaver  .   2006  .   Transforming growth factor-beta induces development 
of the T(H)17 lineage.       Nature    .   441  :  231    –    234  .   
        24  .   Kotake  ,   S.  ,   N.     Udagawa  ,   N.     Takahashi  ,   K.     Matsuzaki  ,   K.     Itoh  ,   S.   
  Ishiyama  ,   S.     Saito  ,   K.     Inoue  ,   N.     Kamatani  ,   M.T.     Gillespie  ,   et al  .   1999  . 
  IL-17 in synovial fl  uids from patients with rheumatoid arthritis is a 
  potent stimulator of osteoclastogenesis.       J. Clin. Invest.       103  :  1345    –    1352  .   
        25  .   Matsui  ,   T.  ,   T.     Akahoshi  ,   R.     Namai  ,   A.     Hashimoto  ,   Y.     Kurihara  ,   M.   
  Rana  ,  A.    Nishimura  ,  H.    Endo  ,  H.    Kitasato  ,  S.    Kawai  ,  et al .  2001  .  Selective 2812 CCR6- AND CCL20-DEPENDENT MIGRATION OF ARTHRITOGENIC TH17 CELLS | Hirota et al.
recruitment of CCR6-expressing cells by increased production of MIP-3 
alpha in rheumatoid arthritis.       Clin. Exp. Immunol.       125  :  155    –    161  .   
        26  .   Ruth  ,   J.H.  ,   S.     Shahrara  ,   C.C.     Park  ,   J.C.     Morel  ,   P.     Kumar  ,   S.     Qin  , and 
  A.E.     Koch  .   2003  .   Role of macrophage infl  ammatory protein-3alpha 
and its ligand CCR6 in rheumatoid arthritis.       Lab. Invest.       83  :  579    –    588  .   
        27  .   Acosta-Rodriguez  ,   E.V.  ,   L.     Rivino  ,   J.     Geginat  ,   D.     Jarrossay  ,   M.   
  Gattorno  ,   A.     Lanzavecchia  ,   F.     Sallusto  , and   G.     Napolitani  .   2007  .   Surface 
phenotype and antigenic specifi  city of human interleukin 17-producing 
T helper memory cells.       Nat. Immunol.       8  :  639    –    646  .   
        28  .   Serafi  ni  ,   B.  ,   S.     Columba-Cabezas  ,   F.     Di Rosa  , and   F.     Aloisi  .   2000  . 
  Intracerebral recruitment and maturation of dendritic cells in the onset 
and progression of experimental autoimmune encephalomyelitis.       Am. J. 
Pathol.       157  :  1991    –    2002  .   
        29  .   Ambrosini  ,   E.  ,   S.     Columba-Cabezas  ,   B.     Serafi  ni  ,   A.     Muscella  , and   F.   
  Aloisi  .   2003  .   Astrocytes are the major intracerebral source of macro-
phage infl  ammatory protein-3alpha/CCL20 in relapsing experimental 
autoimmune encephalomyelitis and in vitro.       Glia    .   41  :  290    –    300  .   
        30  .   Kohler  ,   R.E.  ,   A.C.     Caon  ,   D.O.     Willenborg  ,   I.     Clark-Lewis  , and 
  S.R.     McColl  .   2003  .   A role for macrophage infl  ammatory protein-3 
alpha/CC chemokine ligand 20 in immune priming during T cell-
mediated infl  ammation of the central nervous system.       J. Immunol.       170  :
  6298    –    6306  .             